This publication was written by Elizabeth B. Robertson, Ph.D., University of Alabama (formerly with the National Institute on Drug Abuse), Belinda E. Sims, Ph.D., National Institute on Drug Abuse, and Eve E. Reider, Ph.D., National Center for Complementary and Integrative Health. It was edited by Eric Wargo, Ph.D., National Institute on Drug Abuse.
NIDA wishes to thank the following individuals for their guidance and comments during the development and review of this publication:
Karl G. Hill, Ph.D.
University of Washington
Nicholas S. Ialongo, Ph.D.
Johns Hopkins University
Leslie Leve, Ph.D.
University of Oregon
David L. Olds, Ph.D.
University of Colorado
Naomi Stotland, M.D.
University of California, San Francisco
NIDA also would like to thank the Community Anti-Drug Coalitions of America (CADCA) for helping organize a focus group of community leaders in reviewing this publication and the following individuals who participated in the focus group:
B.J. Boyd, Ph.D.
Cherokee National Behavioral Health
Starfish Family Services
Families in Action, Inc.
Strategic Planning Initiative for Families and Youth
NIDA wishes to thank the following individuals for their contributions to the development of this publication:
Nona Lu, M.D.
Marisa Pinchas, M.P.H.
Children’s Hospital Los Angeles
Sarah D. Lynne Landsman, Ph.D.
University of Florida
This publication is available for your use and may be reproduced in its entirety without permission from NIDA. Citation of the source is appreciated, using the following language: Source: National Institute on Drug Abuse; National Institutes of Health; U.S. Department of Health and Human Services.
The U.S. government does not endorse or favor any specific commercial product or company. Trade, proprietary, or company names appearing in the publication are used only because they are considered essential in the context of the studies described here.